Build the Target Product Profile for the Market at Launch, Not the Market Today

Session details:

• Every pipeline asset is aimed at a market that does not exist yet. Most Target Product Profiles, however, are assembled through weeks of manual benchmarking, captured in static documents, and already outdated by their first governance review.
• Hear where TPP development breaks down across the asset lifecycle, from fragmented evidence collection and inconsistent formats to profiles that go stale as the competitive landscape moves
• Understand why data and technology alone have not closed these gaps, and what changes when analytical platforms are paired with embedded therapeutic and methodological expertise
• See how leading teams benchmark candidate profiles against today's standard of care and against the competitors most likely to be at market at launch
• Leave with a practical framework for turning the TPP from a static document into a living, evidence-grounded strategy that stands up in governance reviews